Friday Dec 31, 2021
Managing COPD patients during the COVID-19 pandemic
Professor Jill Ohar joins Dr Richard Russell for this episode to discuss the management of COPD during the COVID-19 pandemic. Listen as they explore the impact of lockdown on COPD outcomes,1–3 which treatments should be used and how we can continue to improve our use of telemedicine in the future. Following this, Dr Russell will explain the key findings and takeaways from a publication on the risk of acquired Pseudomonas with inhaled corticosteroid use,4 before taking us through this week’s social media hot topic of COPD communities during the pandemic. Keep an eye out for future episodes of Season 3 of the Medical Insider COPD podcast!
1 Alqahtani JS, et al. PLoS One 2021;16:e0255659;
2 Hingham A, et al. Eur Respir Rev 2020;29:200199;
3 Hume E, et al. Breathe 2020;16:200231;
4 Eklöf J, et al. Thorax 2021; doi: https://doi.org/10.1136/thoraxjnl-2021-217160.
Disclosures
Professor Jill Ohar
Professor Jill Ohar reports grants from Boehringer Ingelheim, Sunovion and Teva. She reports advisory board fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mylan, Reckitt Benckiser, Sunovion, Teva, Theravance and Verona.
Bios:
 |
Professor Jill Ohar Jill Ohar is a tenured professor at the Wake Forest School of Medicine, North Carolina, USA, and has served on the faculty at Saint Louis University, Missouri, USA. She is a clinical investigator and the author or co-author of numerous journal articles, reviews, abstracts and book chapters. Some of her work has been published in the American Journal of Respiratory and Critical Care Medicine, the Journal of the American Medical Society and Chest, among others. Her current research interests focus on the diagnosis of and delivery of care to patients with COPD. She is a member and past officer of the American College of Physicians, a member of the American Thoracic Society, and a Fellow of the American College of Chest Physicians. |
This series of podcasts are intended for healthcare professionals only.
The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.
Copyright © 2021, Boehringer Ingelheim Group of Companies. All rights reserved.